Dallah Healthcare Company
4004.SR · Healthcare · · SARFahodi Score STRONG SELL Short-term (Swing)
26
/ 100
Technical
0
Trend & RS
36
Momentum
27
Fundamental (0%)
67
Macro
76
Liquidity
31
| Component | Score | Weight |
|---|---|---|
| Technical | 0.0 | 40% |
| Trend & RS | 35.8 | 20% |
| Momentum | 27.4 | 20% |
| Fundamental | 66.7 | 0% |
| Macro | 75.8 | 15% |
| Liquidity | 30.6 | 5% |
Trade Setup
| Entry | 112.50 |
| Stop Loss | 104.70 (6.9%) |
| Target 1 (1:1) | 120.30 (+6.9%) |
| Target 2 (2:1) | 128.10 (+13.9%) |
| ATR(14) | 3.90 (3.5%) |
| Risk per Share | 7.80 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 70.4 | +0.82 | |
| Momentum | 27.4 | -0.91 | |
| Quality | 38.3 | -0.47 | |
| Composite | 45.4 | ||
Quality Scores
Piotroski F-Score
6
/9 —
Average
✓
✓
✗
✗
✓
✗
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 20.8 | 22.0 | Inline |
| P/B Ratio | 2.8 | 4.0 | Below |
| Dividend Yield | 1.8% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Intrinsic Value (DCF) Significantly Undervalued
Intrinsic Value
168.00
vs
Market Price
112.30
Upside
+49.6%
| Margin of Safety | +33.2% |
| Stage 1 PV (5yr FCF) | 3,349,480,574 |
| Terminal Value PV | 13,635,487,129 |
| Total Enterprise Value | 16,984,967,703 |
Assumptions
| Base FCF | 435,955,914 |
| Growth Rate (5yr) | 25.0% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.5%
Recommended Size
11.65%
Full Kelly
5.83%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 26/100. Estimated win rate 48%, avg win 6.5%, avg loss 4.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
BEAR
Regime: BEAR (20% confidence) — position size reduced 10%
Signal Summary STRONG SELL
0
Bullish Signals
4
Bearish Signals
34.3
RSI(14)
-2.8514
MACD
Relative Strength (RS) WEAK RS
39
/ 99
RS Rating
O'Neil filter: <80
| RS vs TASI | → FLAT (-4.8% vs TASI 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | No (26d since high) |
| Sector Outperformance | +6.3% (3M) |
RS Line — stock / TASI (90 bars)
← older
newer →
RS vs TASI
50-day SMA of RS
WEAK RS:
Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 34.3 | NEUTRAL |
| Macd | -2.8514 | BEARISH |
| Ma Cross | 120.85 / 128.86 | DEATH CROSS |
| Trend Short | BELOW SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.37x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 157.30 |
| Bollinger Upper | 130.0 |
| SMA(200) | 128.86 |
| SMA(50) | 120.85 |
| SMA(20) | 121.04 |
| Current Price | 112.30 |
| Bollinger Lower | 112.08 |
| 52-Week Low | 90.00 |
| ATR(14) | 3.9 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION A
Confidence
75%
Selling Climax
Acc: 3.0 |
Dist: 1.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-05-06 | Normal | 0.75x | Normal bar — no special VSA pattern |
| 2026-05-07 | Normal | 1.07x | Normal bar — no special VSA pattern |
| 2026-05-10 | Stopping Volume | 2.4x | High volume, wide spread, but closes mid — absorption of supply |
| 2026-05-11 | Normal | 1.93x | Normal bar — no special VSA pattern |
| 2026-05-12 | No Supply | 0.37x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud BEARISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 117.90 | Below Kijun |
| Kijun-sen (26) | 124.90 | Base line |
| Senkou A | 121.40 | Leading span A |
| Senkou B | 115.16 | Leading span B |
| Cloud | 115.16 – 121.40 | Bullish (Green) |
| Price vs Cloud | 112.50 | Below Cloud |
| Chikou Span | 134.40 | Bearish |
| Alignment Score | 1/4 | BEARISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH FADING
BB: 112.08 – 130.0 | KC: 115.65 – 126.43
Divergences (last 60 bars)
No significant divergences detected in the last 60 bars.
Anchored VWAP
VWAP: 119.53
Anchor: 2026-03-01 (52w Low)
BELOW AVWAP
-5.9%
Heikin-Ashi Trend
BEARISH
Full data via /api/advanced/4004.SR
Valuation
| Metric | Value |
|---|---|
| Market Cap | 11.35B |
| P/E (TTM) | 20.83 |
| Forward P/E | N/A |
| P/B | 2.78 |
| EPS | 5.39 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 37.3% |
| Profit Margin | 13.2% |
| ROE | 13.7% |
| Debt/Equity | 95.48 |
| Current Ratio | 1.24 |
| Dividend Yield | 1.8% |
| Payout Ratio | N/A |
| Beta | -0.41 |
Trading Data
112.30
Open
112.30
Day High
112.30
Day Low
41.0K
Volume (0.3x avg)
Insider Activity
Insider transaction data is not available for Saudi-listed stocks.
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)